Next Biomedical Co.,Ltd. (KOSDAQ:389650)
53,000
-900 (-1.67%)
At close: Aug 6, 2025, 3:30 PM KST
Next Biomedical Revenue
Next Biomedical had revenue of 3.77B KRW in the quarter ending March 31, 2025, with 165.94% growth. This brings the company's revenue in the last twelve months to 10.95B, up 124.19% year-over-year. In the year 2024, Next Biomedical had annual revenue of 9.54B with 95.46% growth.
Revenue (ttm)
10.95B
Revenue Growth
+124.19%
P/S Ratio
40.10
Revenue / Employee
n/a
Employees
n/a
Market Cap
438.85B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.54B | 4.66B | 95.46% |
Dec 31, 2023 | 4.88B | 2.09B | 74.67% |
Dec 31, 2022 | 2.80B | 527.74M | 23.28% |
Dec 31, 2021 | 2.27B | 6.63M | 0.29% |
Dec 31, 2020 | 2.26B | 1.46B | 182.32% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.76T |
Samsung Biologics | 4,898.69B |
Hanwha Aerospace | 15.28T |
Hyundai Motor Company | 178.98T |
HD Hyundai Heavy Industries | 15.32T |
Doosan Enerbility | 15.88T |